Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease

Allogeneic hematopoietic stem cell transplantation (HSCT) is most commonly a treatment for inborn defects of hematopoiesis or acute leukemias. Widespread use of HSCT, a potentially curative therapy, is hampered by onset of graft-versus-host disease (GVHD), classified as either acute or chronic GVHD....

Descripción completa

Detalles Bibliográficos
Autores principales: Strattan, Ethan, Hildebrandt, Gerhard Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956846/
https://www.ncbi.nlm.nih.gov/pubmed/33673565
http://dx.doi.org/10.3390/ijms22052385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956846/
https://www.ncbi.nlm.nih.gov/pubmed/33673565
http://dx.doi.org/10.3390/ijms22052385

Ejemplares similares